PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRCT PROCEPT BioRobotics

Not Yet Opened 03-04 16:00:00 EST

26.56

+0.30

+1.14%

盘后26.15

-0.41-1.54%

19:48 EST

High27.08	Low26.11	Vol1.31M
Open26.48	D1 Closing26.26	Amplitude3.69%
Mkt Cap1.50B	Tradable Cap1.42B	Total Shares56.39M
T/O34.73M	T/O Rate2.44%	Tradable Shares53.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRCT","market":"US","secType":"STK","nameCN":"PROCEPT BioRobotics","latestPrice":26.56,"timestamp":1772658000000,"preClose":26.26,"halted":0,"volume":1307061,"hourTrading":{"tag":"盘后","latestPrice":26.15,"preClose":26.56,"latestTime":"19:48 EST","volume":31147,"amount":827097.8504,"timestamp":1772671685416,"change":-0.41,"changeRate":-0.015437,"amplitude":0.015437},"delay":0,"changeRate":0.011424219345011316,"floatShares":53564164,"shares":56390196,"eps":-1.720653,"marketStatus":"Not Yet Opened","change":0.3,"latestTime":"03-04 16:00:00 EST","open":26.48,"high":27.08,"low":26.112,"amount":34732836.498213,"amplitude":0.036862,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.720653,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772701200000},"marketStatusCode":0,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":26.26,"preHourTrading":{"tag":"盘前","latestPrice":26.53,"preClose":26.26,"latestTime":"08:48 EST","volume":2942,"amount":77842.225016,"timestamp":1772632121543,"change":0.27,"changeRate":0.010282,"amplitude":0.014471},"postHourTrading":{"tag":"盘后","latestPrice":26.15,"preClose":26.56,"latestTime":"19:48 EST","volume":31147,"amount":827097.8504,"timestamp":1772671685416,"change":-0.41,"changeRate":-0.015437,"amplitude":0.015437},"volumeRatio":0.281636,"impliedVol":0.6327,"impliedVolPercentile":0.5179},"requestUrl":"/m/hq/s/PRCT/tweets","defaultTab":"tweets","newsList":[{"id":"2616837909","title":"Levi & Korsinsky Launches Fraud Probe Into Procept BioRobotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2616837909","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616837909?lang=en_us&edition=fundamental","pubTime":"2026-03-04 04:45","pubTimestamp":1772570727,"startTime":"0","endTime":"0","summary":"Levi & Korsinsky has opened a federal securities-law investigation into Procept Biorobotics Corp. over statements about revenue targets, pricing, and progress toward profitability. The probe follows a pricing change that reduced realized average selling prices, after which the company reported Q4 2025 revenue below prior guidance and issued 2026 revenue guidance that missed analyst expectations, contributing to a sharp one-day stock drop.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL4gc7W0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","BK4082","LU2324357040.USD"],"gpt_icon":0},{"id":"1150174240","title":"Stock Track | PROCEPT BioRobotics Plunges 9.39% in After-Hours Trading Following Multiple Analyst Price Target Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=1150174240","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150174240?lang=en_us&edition=fundamental","pubTime":"2026-03-03 06:38","pubTimestamp":1772491119,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) experienced a significant after-hours plunge of 9.39% on Monday, following a series of analyst price target reductions published earlier in the day.The post-market decline...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRCT"],"gpt_icon":0},{"id":"2616353521","title":"Procept BioRobotics price target lowered to $30 from $62 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2616353521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616353521?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:13","pubTimestamp":1772460784,"startTime":"0","endTime":"0","summary":"UBS analyst Danielle Antalffy lowered the firm’s price target on Procept BioRobotics (PRCT) to $30 from $62 and keeps a Buy rating on the shares. P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-price-target-lowered-to-30-from-62-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/procept-biorobotics-price-target-lowered-to-30-from-62-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1863844749.USD","BK4585","BK4118","PRCT","BK4082","BK4588","UBS","IE0034235071.USD","LU2324357040.USD","LU3187612489.SGD","LU1829250122.USD","LU1863844665.USD","BK4534"],"gpt_icon":0},{"id":"2616358469","title":"PROCEPT BioRobotics Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2616358469","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616358469?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:09","pubTimestamp":1772460540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 02, 2026 09:09 ET (14:09 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"gpt_icon":0},{"id":"2616359013","title":"Truist Adjusts Price Target on PROCEPT BioRobotics to $30 From $47, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2616359013","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616359013?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:55","pubTimestamp":1772459714,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) has an average rating of overweight and mean price target of $34.82, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT"],"gpt_icon":0},{"id":"2616321403","title":"PROCEPT BioRobotics (PRCT) Gets a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2616321403","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616321403?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:57","pubTimestamp":1772456235,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Richard Newitter maintained a Buy rating on PROCEPT BioRobotics today and set a price target of $30.00. Newitter covers th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/procept-biorobotics-prct-gets-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/procept-biorobotics-prct-gets-a-buy-from-truist-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4082","PRCT"],"gpt_icon":0},{"id":"2616875166","title":"PROCEPT BioRobotics (PRCT) Is Down 16.8% After Cutting 2026 Outlook And Widening Q4 Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2616875166","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616875166?lang=en_us&edition=fundamental","pubTime":"2026-03-02 01:17","pubTimestamp":1772385468,"startTime":"0","endTime":"0","summary":"In late February 2026, PROCEPT BioRobotics reported Q4 2025 results showing sales rising to US$76.38 million but a wider quarterly net loss of US$29.85 million, alongside resetting 2026 revenue guidance to US$390 million–US$410 million and issuing new 2027 targets that include 25%–30% revenue growth and a 68%–70% gross margin.\nWhile the company pointed to record procedure volumes, stronger handpiece pricing and a path toward improved margins, investors also had to weigh a larger loss profile...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-down-168-after-cutting-2026-outl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-prct/procept-biorobotics/news/procept-biorobotics-prct-is-down-168-after-cutting-2026-outl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRCT","LU2324357040.USD","BK4082"],"gpt_icon":0},{"id":"1193190391","title":"Stock Track | PROCEPT BioRobotics Plunges 6.90% After Q4 Revenue Miss, Broker Downgrades and Fraud Probe","url":"https://stock-news.laohu8.com/highlight/detail?id=1193190391","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193190391?lang=en_us&edition=fundamental","pubTime":"2026-02-27 09:15","pubTimestamp":1772154939,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) stock experienced a significant 24-hour plunge of 6.90% during Thursday's trading session, reflecting heavy selling pressure.The sharp decline follows the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PRCT"],"gpt_icon":0},{"id":"2614074876","title":"Ademi LLP Probes Possible Securities Fraud at Procept BioRobotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2614074876","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614074876?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:58","pubTimestamp":1772143080,"startTime":"0","endTime":"0","summary":"Ademi LLP said it is investigating potential securities fraud claims against Procept BioRobotics, focusing on whether the company made inaccurate statements about its financial reporting, business operations, and prospects. The probe centers on disclosures related to sales practices and inventory for disposable handpieces used with its aquablation technology, after the company reported quarterly revenue below forecasts and issued 2026 sales guidance below expectations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL2QgzGd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT","BK4082","LU2324357040.USD"],"gpt_icon":0},{"id":"2614020271","title":"Procept Biorobotics Publishes Investor Day Presentation on Aquablation Growth and Profitability Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2614020271","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614020271?lang=en_us&edition=fundamental","pubTime":"2026-02-27 03:06","pubTimestamp":1772132802,"startTime":"0","endTime":"0","summary":"Procept Biorobotics Corporation released an investor day presentation outlining its focus on expanding adoption of its Aquablation therapy for benign prostatic hyperplasia in the U.S. market. The company cited an estimated 40 million U.S. men living with BPH, about 400,000 annual BPH surgical procedures, and approximately 10 percent Aquablation penetration. It also reported more than 125,000 patients treated worldwide and a global installed base of more than 600 systems, and noted Category I reimbursement effective January 1, 2026. The presentation described commercial changes aimed at accelerating procedure growth, including a regional realignment and dedicated launch teams intended to standardize training, reimbursement, and patient education; the company said pilot accounts in Q4 2025 saw about a 50 percent reduction in time from purchase order to the first ten cases. It also discussed exploring leasing pilots and a targeted replacement strategy for capital equipment. You can access","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL7Wbhgc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4082","PRCT"],"gpt_icon":0},{"id":"2614502164","title":"PROCEPT BioRobotics Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2614502164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614502164?lang=en_us&edition=fundamental","pubTime":"2026-02-27 00:51","pubTimestamp":1772124660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRCT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2026 11:51 ET (16:51 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRCT"],"gpt_icon":0},{"id":"2614021677","title":"PROCEPT BioRobotics Down Over 22%, on Track for Lowest Close Since February 2022 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2614021677","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614021677?lang=en_us&edition=fundamental","pubTime":"2026-02-27 00:51","pubTimestamp":1772124660,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics Corp.  is currently at $21.59, down $6.25 or 22.45%. --Would be lowest close since Feb. 23, 2022, when it closed at $21.45. --On pace for largest percent decrease since April 27, 2023, when it fell 25.31%. --Down 78.29% from its all-time closing high of $99.45 on Dec. 4, 2024. --Down 66.79% from 52 weeks ago , when it closed at $65.02. --Down 66.81% from its 52-week closing high of $65.05 on June 5, 2025. --Traded as low as $19.35; lowest intraday level since Feb. 7, 2022, when it hit $18.89. --Down 30.5% at today's intraday low; largest intraday percent decrease on record ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PRCT","LU2324357040.USD"],"gpt_icon":0},{"id":"2614290840","title":"Procept Biorobotics Shares Slump 23.9% After Q4 Revenue Miss, Multiple Brokerages Cut PT","url":"https://stock-news.laohu8.com/highlight/detail?id=2614290840","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614290840?lang=en_us&edition=fundamental","pubTime":"2026-02-27 00:38","pubTimestamp":1772123926,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL4N3ZM1WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","LU2324357040.USD","PRCT"],"gpt_icon":0},{"id":"2614288240","title":"Oppenheimer Downgrades PROCEPT BioRobotics to Perform From Outperform, Removes $60 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2614288240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614288240?lang=en_us&edition=fundamental","pubTime":"2026-02-26 22:17","pubTimestamp":1772115443,"startTime":"0","endTime":"0","summary":"Oppenheimer Downgrades PROCEPT BioRobotics to Perform From Outperform, Removes $60 Price Target","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT","OPY"],"gpt_icon":0},{"id":"2614804262","title":"Procept Biorobotics : Oppenheimer Cuts to Perform From Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2614804262","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614804262?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:24","pubTimestamp":1772112247,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nAZN4SIHZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRCT","BK4082","LU2324357040.USD"],"gpt_icon":0},{"id":"2614426620","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2614426620","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614426620?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:22","pubTimestamp":1772112120,"startTime":"0","endTime":"0","summary":"Procept BioRobotics  shares were down 24% in recent Thursday premarket activity, a day after the company posted a wider Q4 net loss and BofA Securities downgraded the company's stock to underperform from neutral.The Trade Desk  stock was down 17%, a day after the company issued lower-than-expected Q1 revenue guidance.Vir Biotechnology  shares were 16% lower after the company said overnight it priced an underwritten offering of about 17.6 million of its common shares for expected gross proceeds of $150 million.Larimar Therapeutics  stock was down 11%, a day after the company said it priced an upsized public offering of 20 million common shares at $5 each to raise $100 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1720051108.HKD","BK4613","BK4535","BK4585","BK4009","LU1548497426.USD","BK4568","LU1720051017.SGD","BK4082","LRMR","BK4023","LU2357305700.SGD","BK4548","VIR","PRCT","LU0348723411.USD","BK4528","BK4588","BK4139","TTDU","TTD","LU2324357040.USD"],"gpt_icon":1},{"id":"2614042575","title":"PROCEPT BioRobotics Highlights Growth Strategy at Investor Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2614042575","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614042575?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:16","pubTimestamp":1772111783,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics ( ($PRCT) ) has provided an update. On February 26, 2026, PROCEPT BioRobotics held an Investor and Analyst Day at Nasdaq’s New ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/procept-biorobotics-highlights-growth-strategy-at-investor-day?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/procept-biorobotics-highlights-growth-strategy-at-investor-day?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRCT","NQmain","LU2324357040.USD","BK4082"],"gpt_icon":0},{"id":"2614041227","title":"BofA Downgrades PROCEPT BioRobotics to Underperform From Neutral, Price Target is $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2614041227","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614041227?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:59","pubTimestamp":1772110761,"startTime":"0","endTime":"0","summary":"PROCEPT BioRobotics (PRCT) has an average rating of overweight and mean price target of $42.36, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRCT"],"gpt_icon":0},{"id":"2614411360","title":"Procept BioRobotics Forecasts 27%-33% Revenue Growth in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2614411360","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614411360?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:55","pubTimestamp":1772110516,"startTime":"0","endTime":"0","summary":"Procept Biorobotics issued financial guidance for 2026 to 2027, forecasting strong revenue growth and expanding profitability. The company expects 2026 revenue growth of 27% to 33% alongside higher procedure growth of 39% to 48%, indicating procedures are projected to outpace revenue. For 2027, it guided to revenue growth of 25% to 30%. Procept also projected gross margin improvement from 65% in 2026 to 68% to 70% in 2027, with positive adjusted EBITDA expected in Q4 2026 and adjusted EBITDA of $25 million to $30 million in 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL17pjBq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU0314104364.USD","SG9999014021.USD","IE00BKPKM429.USD","SG9999014005.SGD","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","LU2095319765.USD","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","NDAQ","BK4588","LU2324357040.USD","BK4082","SG9999014039.USD","PRCT"],"gpt_icon":0},{"id":"2614044864","title":"PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2614044864","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614044864?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:55","pubTimestamp":1772110500,"startTime":"0","endTime":"0","summary":"Company outlines path to leadership in BPH, including near-term focus on procedure growth through patient-centric solutions and increased organizational disciplineStrong revenue outlook, procedure gro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/26/3245487/0/en/PROCEPT-BioRobotics-Hosts-2026-Investor-Day-to-Detail-Multi-year-Financial-Outlook-and-Strategic-Plan-for-Long-Term-Growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PRCT","LU2324357040.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.procept-biorobotics.com","stockEarnings":[{"period":"1week","weight":-0.046},{"period":"1month","weight":-0.0885},{"period":"3month","weight":-0.2504},{"period":"6month","weight":-0.3471},{"period":"1year","weight":-0.5913},{"period":"ytd","weight":-0.1558}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0148},{"period":"3month","weight":0.0011},{"period":"6month","weight":0.0585},{"period":"1year","weight":0.1877},{"period":"ytd","weight":0.0047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.079362},{"month":2,"riseRate":0.4,"avgChangeRate":0.005067},{"month":3,"riseRate":0.6,"avgChangeRate":0.051494},{"month":4,"riseRate":0.75,"avgChangeRate":0.021233},{"month":5,"riseRate":1,"avgChangeRate":0.132144},{"month":6,"riseRate":0.25,"avgChangeRate":-0.048608},{"month":7,"riseRate":0.5,"avgChangeRate":0.00614},{"month":8,"riseRate":0.5,"avgChangeRate":0.030761},{"month":9,"riseRate":0.5,"avgChangeRate":-0.027813},{"month":10,"riseRate":0.6,"avgChangeRate":0.021826},{"month":11,"riseRate":0.4,"avgChangeRate":0.016944},{"month":12,"riseRate":0.2,"avgChangeRate":-0.059852}],"exchange":"NASDAQ","name":"PROCEPT BioRobotics","nameEN":"PROCEPT BioRobotics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PROCEPT BioRobotics,PRCT,PROCEPT BioRobotics股票,PROCEPT BioRobotics股票老虎,PROCEPT BioRobotics股票老虎国际,PROCEPT BioRobotics行情,PROCEPT BioRobotics股票行情,PROCEPT BioRobotics股价,PROCEPT BioRobotics股市,PROCEPT BioRobotics股票价格,PROCEPT BioRobotics股票交易,PROCEPT BioRobotics股票购买,PROCEPT BioRobotics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PROCEPT BioRobotics(PRCT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PROCEPT BioRobotics(PRCT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}